On June 7th, Haier Biotechnology announced that in order to continuously improve the barriers to Stirling refrigeration technology, achieve independent and controllable core components, and expand the business layout in the low-temperature field, the company plans to increase the capital of its participating company Shanghai Chaolian Technology Co., Ltd. with its own funds of 43 million yuan through installment payments. Shanghai Chaolian Technology Co., Ltd. (hereinafter referred to as “Chaolian”) is a leading Stirling refrigeration solution service provider in the world. After the capital increase, Haier Biological’s shareholding ratio increased from 15% to 54.31%.
This merger and acquisition will further enhance Haier Biotechnology’s leadership in low-temperature technology platforms, solve the “neck” problem of the core components of Stirling ultra-low temperature storage boxes, and further extend to new scenarios such as low-temperature treatment, infrared detection, hazardous chemical detection, and low-temperature cryotherapy in the future, providing new impetus for the company’s long-term sustainable development in the low-temperature field.
Stirling refrigeration technology has strong advantages in safety, energy conservation, stability, and other aspects. It uses helium as the refrigeration medium, with a minimum temperature of -196 ℃ or below. At the same time, it has higher refrigeration efficiency, saving 50% energy compared to compressor refrigeration, and improving reliability by 100%. Compared to the widespread application of Stirling refrigeration technology abroad, China is currently in a rapid development stage in this field. Against the backdrop of carbon neutrality becoming the development goal of the entire industry, the industrial application of Stirling refrigeration technology is an inevitable choice for the development of the refrigeration industry. In addition, the application fields of Stirling refrigerators are also constantly expanding. In addition to traditional medical, pharmaceutical and other industries, the applications of Stirling refrigerators in new energy, aerospace, military and other fields are also constantly expanding, which will bring more opportunities and potential to the Stirling refrigeration market.
Chaolian is mainly engaged in the research and development, production, and sales of Stirling refrigerators. Since its establishment, it has been committed to the industrial application of Stirling refrigeration technology. As a key component, the main product Stirling refrigerators have been applied in various fields such as low-temperature storage, low-temperature treatment, and infrared detection. The company has a first-class Stirling refrigeration research team in China, and team members have rich experience in the application of Stirling refrigeration technology in aerospace and other fields. As a national high-tech enterprise, Super Lian has fully independent intellectual property rights in the fields of Stirling low-temperature refrigerators and vacuum packaging. Currently, it has obtained 12 patents (including 4 invention patents), and its main business, Stirling refrigerator product series, will achieve mass production and commercialization starting from 2024.
Haier Biotechnology started with the research and development, production, and sales of biomedical low-temperature storage devices. It is a digital scene ecological brand for life sciences and medical innovation based on the transformation of the Internet of Things. The company is committed to building a leading capability with high efficiency and reliability. A few years ago, it launched a scientific research project on “Efficient, Disturbance-resistant Stirling Refrigerator Control System and Its Application in Ultra Low Temperature Refrigerators”, and successfully broke through the technical difficulties of efficient Stirling Refrigerator control, achieving high efficiency and reliability in control.
Post time: Jun-15-2023